(MedPage Today) — ORLANDO — Two-thirds of patients with moderate or severe plaque psoriasis had complete or nearly complete clearance at 4 months with an oral peptide targeting interleukin (IL)-23, a randomized study showed.
The primary analysis…
Source link : https://www.medpagetoday.com/meetingcoverage/aad/114558
Author :
Publish date : 2025-03-09 21:21:00
Copyright for syndicated content belongs to the linked Source.
